A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098
Condition(s):Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)Last Updated:January 19, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)Last Updated:January 19, 2023Recruiting
Condition(s):Tuberculosis, PulmonaryLast Updated:November 21, 2023Completed
Condition(s):Frontotemporal DementiaLast Updated:February 21, 2024Active, not recruiting
Condition(s):Tuberculosis; Resistance Bacterial; Diagnoses DiseaseLast Updated:November 27, 2023Active, not recruiting
Condition(s):Tuberculosis; Multidrug Resistant Tuberculosis; Extensively-drug Resistant TuberculosisLast Updated:September 29, 2021Completed
Condition(s):Multidrug-resistant TuberculosisLast Updated:April 29, 2021Completed
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:September 1, 2023Terminated
Condition(s):Drug Resistant Tuberculosis; MDR-TB; XDR-TB; TuberculosisLast Updated:February 20, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:July 22, 2022Completed
Condition(s):HIV Infections; TuberculosisLast Updated:November 3, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.